Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Report

NOVAVAX, INC

via NOVAVAX, INC

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 20, 2026Filing document ↗LDA record ↗

Expenses$110Kself-filed spend

Client

Name: NOVAVAX, INC
Location: Maryland · United States of America

Registrant

Firm: NOVAVAX, INC
Description: clinical-stage vaccine company
Location: Gaithersburg, Maryland, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks
LobbyistsKELLY CAPPIO · JAMES CAMPOLONGO
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

NOVAVAX, INC — Lobbying — Receipts Report